Childhood obesity affects 1 in 5 children in the U.S., yet most families have limited access to specialized weight-management ...

Family-centered behavioral therapy induced greater reductions in median BMI than standard of care for children and adolescents with obesity, according to findings from the TEAM UP trial published in ...

This month, the Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge, a demonstration program that ...

After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body ...

More than 3 million adults in Ohio (nearly 37% of our population!) live with obesity. This is not a personal failing; it is a complex, chronic disease crisis that is worsening each year and demands a ...

Children who respond well to pediatric obesity treatment have markedly lower morbidity and mortality risks in young adulthood, according to data published on January 21 in JAMA Pediatrics. Researchers ...

Childhood obesity affects one in five children in the U.S., yet most families have limited access to specialized ...

Obesity treatment has entered a new era with innovative medications offering transformative results. Yet, a troubling reality persists: many who need these life-changing treatments most face the ...

Obesity care is evolving fast, but experts at ICO 2026 warned that access to treatment, prevention strategies, and policy ...

Hoosiers insured through Medicaid will soon gain access to GLP-1 medications for obesity. Gov. Mike Braun on Thursday ...

Exclusive: Hanmis EPPE Challenges Wegovy, Mounjaro in Obesity Market First domestic obesity drug tailored for Korean patients ...